Quantifying the Benefit of Non-Small-Cell Lung Cancer Immunotherapy

The Lancet - United Kingdom
doi 10.1016/s0140-6736(19)32503-6
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Elsevier BV

Related search

Quantifying the Benefit of Non-Small-Cell Lung Cancer Immunotherapy – Authors' Reply

The Lancet
Medicine
2019English

Latest Immunotherapy Methods in Non-Small Cell Lung Cancer Treatment

Juntendo Medical Journal
2019English

Potential Role of Immunotherapy in Advanced Non-Small-Cell Lung Cancer

OncoTargets and Therapy
OncologyPharmacology
2016English

Review of Checkpoint Immunotherapy for the Management of Non-Small Cell Lung Cancer

ImmunoTargets and Therapy
AllergyImmunology
2018English

Immunotherapy in Extensive Small Cell Lung Cancer

Experimental Hematology and Oncology
Cancer ResearchOncologyHematology
2019English

Immunotherapy in Non-Small Cell Lung Cancer: The Past, the Present, and the Future

Thoracic Cancer
MedicinePulmonaryRespiratory MedicineOncology
2019English

FDA Approves Breakthrough Immunotherapy for Patients With Non-Small-Cell Lung Cancer

Cancer
Cancer ResearchOncology
2017English

Non-Small Cell Lung Cancer

English

Pseudoprogression in Non–Small Cell Lung Cancer Upon Immunotherapy: Few Drops in the Ocean?

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy